Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer

von Parcesepe, Pietro, Giordano, Guido, Laudanna, Carmelo, Febbraro, Antonio, Pancione, Massimo
Veröffentlicht in Gastroenterol Res Pract (2016)

Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis

von Pancione, Massimo, Giordano, Guido, Remo, Andrea, Febbraro, Antonio, Sabatino, Lina, Manfrin, Erminia, Ceccarelli, Michele, Colantuoni, Vittorio
Veröffentlicht 2014

Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports

von Giordano, Guido, Febbraro, Antonio, Quaquarini, Erica, Turletti, Anna, Pedersini, Rebecca, Raffaele, Mimma, Villa, Federica, Rossello, Rosalba
Veröffentlicht in Oncology (2018)

Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept

von Giordano, Guido, Febbraro, Antonio, Venditti, Michele, Campidoglio, Serena, Olivieri, Nunzio, Raieta, Katia, Parcesepe, Pietro, Imbriani, Giusy Carmen, Remo, Andrea, Pancione, Massimo
Veröffentlicht 2014

Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome

von Pancione, Massimo, Sabatino, Lina, Fucci, Alessandra, Carafa, Vincenzo, Nebbioso, Angela, Forte, Nicola, Febbraro, Antonio, Parente, Domenico, Ambrosino, Concetta, Normanno, Nicola, Altucci, Lucia, Colantuoni, Vittorio
Veröffentlicht 2010

Correction: Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome

von Pancione, Massimo, Sabatino, Lina, Fucci, Alessandra, Carafa, Vincenzo, Nebbioso, Angela, Forte, Nicola, Febbraro, Antonio, Parente, Domenico, Ambrosino, Concetta, Normanno, Nicola, Altucci, Lucia, Colantuoni, Vittorio
Veröffentlicht 2011

Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Regi...

von Riccardi, Ferdinando, Colantuoni, Giuseppe, Diana, Anna, Mocerino, Carmela, Cartenì, Giacomo, Lauria, Rossella, Febbraro, Antonio, Nuzzo, Francesco, Addeo, Raffaele, Marano, Ombretta, Incoronato, Pasquale, De Placido, Sabino, Ciardiello, Fortunato, Orditura, Michele
Veröffentlicht in Mol Clin Oncol (2018)

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice

von De Vita, Ferdinando, Ventriglia, Jole, Febbraro, Antonio, Laterza, Maria Maddalena, Fabozzi, Alessio, Savastano, Beatrice, Petrillo, Angelica, Diana, Anna, Giordano, Guido, Troiani, Teresa, Conzo, Giovanni, Galizia, Gennaro, Ciardiello, Fortunato, Orditura, Michele
Veröffentlicht in BMC Cancer (2016)

Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pai...

von Garassino, Marina Chiara, Piva, Sheila, La Verde, Nicla, Spagnoletti, Ilaria, Iorno, Vittorio, Carbone, Claudia, Febbraro, Antonio, Bianchi, Anna, Bramati, Annalisa, Moretti, Anna, Ganzinelli, Monica, Marabese, Mirko, Gentili, Marta, Torri, Valter, Farina, Gabriella
Veröffentlicht 2013

Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting

von Prete, Salvatore Del, Montella, Liliana, Arpino, Grazia, Buono, Giuseppe, Buonerba, Carlo, Dolce, Pasquale, Fiorentino, Olga, Aliberti, Maria, Febbraro, Antonio, Savastano, Clementina, Colantuoni, Giuseppe, Riccardi, Ferdinando, Ruggiero, Angela, Placido, Sabino De, Orditura, Michele
Veröffentlicht in Oncotarget (2020)

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer

von Giordano, Guido, Febbraro, Antonio, Tomaselli, Eugenio, Sarnicola, Maria Lucia, Parcesepe, Pietro, Parente, Domenico, Forte, Nicola, Fabozzi, Alessio, Remo, Andrea, Bonetti, Andrea, Manfrin, Erminia, Ghasemi, Somayehsadat, Ceccarelli, Michele, Cerulo, Luigi, Bazzoni, Flavia, Pancione, Massimo
Veröffentlicht in J Exp Clin Cancer Res (2015)

Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after fir...

von Cardone, Claudia, Martinelli, Erika, Troiani, Teresa, Sforza, Vincenzo, Avallone, Antonio, Nappi, Anna, Montesarchio, Vincenzo, Andreozzi, Francesca, Biglietto, Maria, Calabrese, Filomena, Bordonaro, Roberto, Cordio, Stefano, Bregni, Giacomo, Febbraro, Antonio, Garcia-Carbonero, Rocio, Feliu, Jaime, Cervantes, Andrés, Ciardiello, Fortunato
Veröffentlicht in ESMO Open (2019)

Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience

von Lutrino, Eufemia S., Orlando, Laura, Febbraro, Antonio, Giampaglia, Marianna, Zamagni, Claudio, Schiavone, Paola, Scavelli, Claudio, Dima, Gianluca, Fedele, Palma, Giordano, Guido, Bilancia, Domenico, Quaranta, Anna Maria, Rubino, Daniela, Filippelli, Gianfranco, Fontanella, Caterina, Caliolo, Chiara, Marino, Antonella, Calvani, Nicola, Ferrara, Pasqualinda, Cinieri, Saverio
Veröffentlicht in Tumori (2019)

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian canc...

von Pignata, Sandro, De Placido, Sabino, Biamonte, Rosalbino, Scambia, Giovanni, Di Vagno, Giovanni, Colucci, Giuseppe, Febbraro, Antonio, Marinaccio, Marco, Vernaglia Lombardi, Alessandra, Manzione, Luigi, Cartenì, Giacomo, Nardi, Mario, Danese, Saverio, Valerio, Maria Rosaria, de Matteis, Andrea, Massidda, Bruno, Gasparini, Giampietro, Di Maio, Massimo, Pisano, Carmela, Perrone, Francesco
Veröffentlicht 2006

Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)

von Orditura, Michele, Gravina, Adriano, Riccardi, Ferdinando, Diana, Anna, Mocerino, Carmela, Leopaldi, Luigi, Fabozzi, Alessio, Giordano, Guido, Nettuno, Raffaele, Incoronato, Pasquale, Barzelloni, Maria Luisa, Caputo, Roberta, Pisano, Agata, Grimaldi, Giuseppe, Genua, Geppino, Montesarchio, Vincenzo, Barbato, Enrico, Iodice, Giovanni, Lieto, Eva, Procaccini, Eugenio, Mabilia, Roberto, Febbraro, Antonio, Laurentiis, Michelino De, Ciardiello, Fortunato
Veröffentlicht in ESMO Open (2017)

Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey

von Silvestris, Nicola, Pantano, Francesco, Ibrahim, Toni, Gamucci, Teresa, De Vita, Fernando, Di Palma, Teresa, Pedrazzoli, Paolo, Barni, Sandro, Bernardo, Antonio, Febbraro, Antonio, Satolli, Maria Antonietta, Bertocchi, Paola, Catalano, Vincenzo, Giommoni, Elisa, Comandone, Alessandro, Maiello, Evaristo, Riccardi, Ferdinando, Ferrara, Raimondo, Trogu, Antonio, Berardi, Rossana, Leo, Silvana, Bertolini, Alessandro, Angelini, Francesco, Cinieri, Saverio, Russo, Antonio, Pisconti, Salvatore, Brunetti, Anna Elisabetta, Azzariti, Amalia, Santini, Daniele
Veröffentlicht 2013

Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC

von Perrone, Francesco, Baldassarre, Gustavo, Indraccolo, Stefano, Signoriello, Simona, Chiappetta, Gennaro, Esposito, Franca, Ferrandina, Gabriella, Franco, Renato, Mezzanzanica, Delia, Sonego, Maura, Zulato, Elisabetta, Zannoni, Gian F., Canzonieri, Vincenzo, Scambia, Giovanni, Sorio, Roberto, Savarese, Antonella, Breda, Enrico, Scollo, Paolo, Ferro, Antonella, Tamberi, Stefano, Febbraro, Antonio, Natale, Donato, Maio, Massimo Di, Califano, Daniela, Scognamiglio, Giosuè, Lorusso, Domenica, Canevari, Silvana, Losito, Simona, Gallo, Ciro, Pignata, Sandro
Veröffentlicht in Oncotarget (2016)

Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

von Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Valerio, Maria Rosaria, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati, Lucrezia, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia, Artale, Salvatore, Blasi, Livio, Piezzo, Michela, Atzori, Francesco, Turletti, Anna, Benedetto, Chiara, Cursano, Maria Concetta, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Alessio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Torri, Valter
Veröffentlicht in Oncotarget (2018)

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

von Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Ancona, Cristina, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati, Lucrezia, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia, Artale, Salvatore, Blasi, Livio, Piezzo, Matilde, Atzori, Francesco, Turletti, Anna, Benedetto, Chiara, Cursano, Maria Concetta, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Antonio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Torri on behalf of The EVA Study Group, Valter
Veröffentlicht in Oncotarget (2018)

Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

von Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Valerio, Maria Rosaria, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati, Lucrezia, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia, Artale, Salvatore, Blasi, Livio, Piezzo, Matilde, Atzori, Francesco, Turletti, Anna, Benedetto, Chiara, Cursano, Maria Concetta, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Alessio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Torri on behalf of The EVA Study Group, Valter
Veröffentlicht in Oncotarget (2018)